Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Nephrology

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Autoimmune hemolytic anemia occurred prior to evident nephropathy in a patient with chronic hepatitis C virus infection: case report

  • Isao Ohsawa1Email author,
  • Yuki Uehara2,
  • Sumiko Hashimoto3,
  • Morito Endo1,
  • Takayuki Fujita1 and
  • Hiroyuki Ohi1
BMC Nephrology20034:7

https://doi.org/10.1186/1471-2369-4-7

Received: 28 March 2003

Accepted: 29 August 2003

Published: 29 August 2003

Abstract

Background

Renal involvement in patients with chronic hepatitis C virus infection has been suggested to be due to a variety of immunological processes. However, the precise mechanism by which the kidneys are damaged in these patients is still unclear.

Case presentation

A 66 year old man presented with the sudden onset of autoimmune hemolytic anemia. Concomitant with a worsening of hemolysis, his initially mild proteinuria and hemoglobinuria progressed. On admission, laboratory tests revealed that he was positive for hepatitis C virus in his blood, though his liver function tests were all normal. The patient displayed cryoglobulinemia and hypocomplementemia with cold activation, and exhibited a biological false positive of syphilic test. Renal biopsy specimens showed signs of immune complex type nephropathy with hemosiderin deposition in the tubular epithelial cells.

Conclusions

The renal histological findings in this case are consistent with the deposition of immune complexes and hemolytic products, which might have occurred as a result of the patient's underlying autoimmune imbalance, autoimmune hemolytic anemia, and chronic hepatitis C virus infection.

Background

Extra-hepatic manifestations of hepatitis C virus (HCV) infection are diverse and appear during late middle age [13]. Among these, glomerulonephritis, arthritis, dermal vasculitis and sialadenitis are thought to develop as a result of the deposition of immune complexes (IC). It is generally accepted that B-cells infected with HCV clonally expand and produce autoantibodies [4, 5]. When antigen-bound, these autoantibodies, along with anti-HCV antibodies that target viral epitopes on the surface of cells are known to circulate as IC. These IC may participate in the pathogenesis of HCV-associated glomerulonephritis, though it has been difficult to detect these IC clinically. While immunosuppressive agents have been used successfully to diminish the production of autoantibodies, such a strategy is contraindicated in HCV patients since it would lead to an increase in viral replication.

We herein report the case of a patient with extra-hepatic manifestations of chronic HCV infection that developed autoimmune hemolytic anemia (AIHA) prior to evident nephropathy.

Case presentation

A 66 year old man, with no prior history of blood transfusion, drug addiction, or the acquisition of tattoos, was diagnosed with hemolytic anemia in June of 2000. From the time he was 50, his yearly health check-ups have revealed faint hematuria (±) by urine dipstick testing, and he first exhibited proteinuria when he was 60 years old (see Table 1 for the patient's clinical history). At no time did the patient shows signs of liver dysfunction. Two of the patient's five brothers suffered from chronic liver disease (no further information was available) but none had a history of anemia.
Table 1

Past laboratory findings before admission

date

 

1998/

1999/

2000/

   

2001/

  
  

3/27

3/4

3/24

7/21

9/11

12/18

1/30

2/7

normal range

RBC

(/μl)

525

528

334

272

236

213

226

225

(374–502)

Hb

(g/dl)

16.9

16.7

12.3

10.2

9.5

8.5

9.3

8.1

(11.1–15.3)

Htc

(%)

49.6

49.5

34.5

28.8

26.2

24.1

25.6

24.8

(33.2–45.3)

   MCV

(fl)

94.5

93.8

103.3

105.9

111.0

113.1

113.3

110.2

(85.0–100.0)

   MCH

(pg)

32.2

31.6

36.8

37.5

40.3

39.9

41.2

36.0

(30.0–35.0)

   MCHC

(g/dl)

34.1

33.7

35.7

35.4

36.3

35.3

36.3

32.7

(32.0–36.0)

LDH

(U/l)

371

 

878

1032

1348

1194

1022

1082

(220–430)

TP

(g/dl)

8.1

 

7.6

7.1

7.4

6.2

6.3

6.3

(6.5–8.0)

Urine

          

   Protein*

 

+

+

+

±

2+

3+

3+

3+

 
 

(mg/dl)

73

75

78

 

114

480

246.8

99.8

 

   Occult blood reaction*

 

±

±

±

±

2+

3+

3+

3+

 

*: urine dip-stick test RBC: red blood cell, Hb: hemoglobin, Htc: hematocrit, MCV: mean corpuscular volome, MCH: mean corpuscular hemoglobin, MCHC: mean corpuscular hemoglobin concentration, LDH: lactate dehydogenase, TP: total protein

In March of 2000, the patient was diagnosed with sudden onset anemia characterized by an increase in both mean corpuscular volume and corpuscular hemoglobin. Result of the Coomb's, acidified serum, sucrose hemolysis, and cold agglutinin tests were negative. Because spherocytes predominated in his hemogram and the results of his erythroresistant test (Ribiere's test) were positive, he was provisionally diagnosed as having hemolytic anemia caused by spherocytosis. Since he was asymptomatic, he was followed without medication.

Starting in September of 2000, the patient's hematuria and proteinuria progressed and his hemolysis worsened. Laboratory data began to indicate an increase in urinary protein excretion and a lowered serum protein concentration. The patient began to experience mild pretibial edema in March of 2001, at which time he was admitted to our hospital and a renal biopsy performed. Hematological tests at that time revealed the hyperchromic anemia with a macrocytic pattern and an increased numbers of reticulocytes. A hemogram (Figure 1) revealed the presence of unusually-shaped red blood cells (RBC), and polychromatic cells and spherocytes. Ferokinetic parameters such as Fe, unsaturated iron binding capacity (UIBC), ferritin and transferrin levels were all within the normal range. However, low levels of haptoglobin (less than 10 mg/dl; normal range = 41–341 mg/dl) and extremely high levels of erythropoietin (114 mU/ml; normal range = 8–36 mU/ml) were detected. Unlike his earlier results, his direct Coombs test was now positive and binding of IgG to the RBC surface was observed using anti-human globulin monospecific antibodies. Screening for the target antigen was performed using a panel of RBCs (Resolve® Panel C, Lot no. RC246, Ortho-Clinical Diagnostics, Inc.) and revealed aggregation with all types of RBCs. Serum chemistry tests showed high levels of bilirubin and LDH, presumably caused by the excessive hemolysis (Table 2). Moderate levels of protein were found in the urine but serum total protein levels were slightly below the normal range. Urine dipstick testing gave a false positive result for occult blood detection. The slide precipitation test for syphilis also resulted in a false positive reading, though anti-cardiolipin β2GPI antibodies were absent. Hypocomplementemia with cold activation was demonstrated with the serum titer of CH50 being low though plasma titers were recoverable (his blood was collected in EDTA-containing tubes). Cryoprecipitation under cold storage (4°C, 72 hrs) followed by immunoelectrophoresis revealed the presence of a mixed type II cryogobulinemia. HCV viremia was confirmed using an HCV-RNA PCR test (genotype: 1B). Antibodies directed against HBV, HIV, EBV, and CMV were not found. An abdominal echogram revealed the absence of a splenomegaly and showed that his liver was of normal size and that it had a smooth surface.
Figure 1

Hemogram (May of 2001). Red blood cells showed anisocytosis, polychromatosis, and poikilocytosis. Note the presence of polychromatic cells (arrow) and spherocytes (double arrow) in the figure.

Table 2

Laboratory findings on admission

CBC

  

normal range

WBC

14700

/μl

3600–9100

RBC

221

×104/μl

374–502

Hb

8.7

g/dl

11.1–15.3

Htc

24.7

%

33.2–45.3

   MCV

112

fl

85.0–100.0

   MCH

39.4

pg

30.0–35.0

   MCHC

35.1

g/dl

32.0–36.0

Platelet

29.3

×104/μl

13.0–37.0

Reticulocyte

236

8.0–20.0

Biochemistry

   

T. bilirubin

2.18

mg/dl

0.30–1.20

D. bilirubin

0.69

mg/dl

0.05–0.40

AST

41

U/l

8–38

ALT

16

U/l

4–44

LDH

1044

U/l

220–430

ALP

172

U/l

117–335

ChE

219

U/l

200–450

BUN

16.0

mg/dl

8.0–19.0

Cr

1.07

mg/dl

0.80–1.30

UA

9.1

mg/dl

3.9–7.8

Na

140

mmol/l

136–148

K

4.3

mmol/l

3.6–5.0

Cl

107

mmol/l

98–109

TP

6.3

g/dl

6.5–8.0

Albumin

3.69

g/dl

3.8–5.3

T. cholesterol

161

mg/dl

130–220

Triglyceride

137

mg/dl

55–150

Syphilis

   

   STS slide precipitation test

1+

 

negative

   TPHA

-

 

negative

Hepatitis virus

   

HBs Ag

-

 

negative

HCV

   

   Ab

+

 

negative

 

108.5

S/CO

 

   RNA

220

KIU/ml

 

genotype

1B

  

Immunology

   

IgG

1497

mg/dl

870–1700

IgA

246

mg/dl

110–410

IgM

152

mg/dl

35–220

ANA

40

dilution

<80

anti-ds DNA ab

<2.0

IU/ml

<6.0

anti-CL-β2GPI ab

1.8

U/ml

<3.5

RF

<12

IU/ml

<20

ASO

20

IU/ml

<200

CRP

<0.1

mg/dl

<0.20

C3

68

mg/dl

60–140

C4

16

mg/dl

10–40

CH50

21.5

U/ml

30.0–45.0

Immune complex

   

C1q-assay

<1.5

μg/ml

<3.0

C3d-assay

8.8

μg/ml

<3.0

Cryoglobulin

2+

 

negative

   (monoclonal IgMk+polyclonal IgG)

Urinary examination

Protein

2.2

g/day

0.03–0.12

Creatine clearance

83.5

ml/min.

70.0–130.0

NAG

5.0

U/l

<5.0

β2-microglobulin

137

μ g/l

5–300

Urinalysis

   

pH

6.0

 

5.0–7.0

SG

1.010

 

1.005–1.020

Protein

2+

 

-

Occult blood

3+

 

-

Keton

-

 

-

Sediment

   

   RBC

5–9/HF

  

   WBC

10–19/HF

  

   Epithel

1–4/HF

  

   Tubular cell

1–4/HF

  

Cast

   

   Hyalin

0–1/LF

  

   Glanular

-

  

Oval fat body

+

  

Because the patient was symptom free, he was discharged after his renal biopsy and was followed without treatment. One year later, the patient had the same degree of hemolysis (hemoglobin = 7.4 g/dl, LDH = 756 U/l, total bilirubin = 2.7 g/dl) though his creatinine clearance had decreased (69.5 ml/min.). However, his urinary protein was stable (1.6 g/day) and his serum total protein recovered into the normal range (7.1 g/dl). His liver function was near normal (AST = 57 U/l, ALT = 19 U/l, albumin = 3.5 g/dl). And his level of HCV-RNA was slightly reduced (130 KIU/ml).

Renal histology (Figure 2 and 3): Five glomeruli were visualized in the patient's biopsy specimen. One of these glomeruli was intact while the other four, which were mildly lobulated, appeared to show a slight increase in mesangial cells and matrix. The glomerular basement membrane (GBM) was partially thickened and PAS staining revealed small spikes and bubble formation. No glomeruli had GBM cryoglobulinemic deposits. Small fibro-cellular crescents were found in two glomeruli. The proximal tubular epithelial cells contained numerous hemosiderin granules.
Figure 2

Renal tissue (Light microscopy, PAS stain, × 200). The patient's glomeruli showed partial thickening of the GBM and exhibited some mesangial proliferation. Hemosiderin deposits were seen in the cytosol of proximal tubular epithelial cells (arrowhead).

Figure 3

Renal tissue (Immunofluorescence, × 100). Extensive deposition of IgG was demonstrated in the GBM using an anti-human IgG monoclonal antibody.

Immunofluorescence histochemistry demonstrated the presence of IgG in the GBM that was distributed in a course granular pattern, as well as the presence of IgA in the GBM and mesangial area. Staining for IgM and C3c was faint in the mesangial area, while C3d, C4d, C1q and fibrinogen were undetectable. Electron microscopy revealed small subepithelial deposits and a few para-mesangial deposits in the glomerulus.

Conclusions

In our patient, IgG autoantibody, which binds to RBCs, was detected in our patient using the direct antiglobulin test (Coomb's test), leading us to conclude that AIHA was the primary pathogenic mechanism that resulted in his hemolysis. Since his serum reacted with the full panel of RBCs tested, his autoantibodies probably recognized a common RBC surface antigen. Recent studies which suggest that the possible target antigens in AIHA are band 3 or 4.1 peptides, Rh, or glycophorin A, all of which are expressed on RBCs [68]. Our patient had not been treated with any antiviral drugs, such as ribavirin®, which have been shown to induce hemolytic anemia by a mechanism involving the oxidation-induced aggregation of band 3, leading to the binding of autologous anti-band 3 antibodies (natural antibody); when activated by complement, these antibodies induce intra- or extra-capillary hemolysis [9]. As a matter of course, ribavirin® was contraindicated in our case. In any event, a similar hemolytic mechanism might have resulted in this patient's production of circulating immune complex and free iron which lodged into his kidney.

HCV-associated glomerulonephritis is characterized by two types of histological changes i.e., membranoproliferative glomerulonephritis and membranous nephropathy (MN) [10, 11]. Since the deposition of immunoglobulin and complement is detected on the glomeruli in this condition, these histological changes are thought to be due to immune complex disease [1012]. In our case, proliferative changes were slight, and immunoglobulins and complement breakdown products were found to be deposited primarily in the GBM. Therefore, the primary histological changes in our patient's kidney were classified as being of the MN type. We speculate that glomerular deposition of IC occurred during chronic progression of the disease when the ratio of antigen and antibody was optimized.

There were no direct evidence of a causal relationship between chronic HCV infection and the occurrence of AIHA in our patient, though such a relationship has been suggested in four published reports [1316]. Two of four patients that received an orthotopic liver transplant (OLT) were reported to have developed AIHA [13, 14]. Though the pathogenesis of AIHA was not discussed in those studies, it may have been related to the strong immunosuppressive therapy that the post-OLT patients received. Another reported case of AIHA was reported in a patient who suffered from B cell chronic lymphocytic leukemia who was being treated with intermittent chemotherapy [15], while still another case was reported in a patient who had a complete congenital deficiency of IgA [16]. Thus, the immune systems of the above four patients were compromised prior to their development of hemolysis. What is not known is how chronic HCV infection leads to AIHA. The following evidence suggested that this patient's chronic immunological imbalance was triggered by chronic HCV infection. 1) HCV viremia was confirmed. 2) Our patient was of late middle age and this age group was shown to have a high frequency of extra-hepatic manifestations of HCV infection [1, 3]. 3) It is accepted that the presence of cryoglobulinemia, hypocomplementemia (cold activation), and a biological false positive on the syphilic test are characteristic abnormalities in patients with chronic HCV infection [1, 12, 17, 18]. In just recently paper, Ramos et al. reviewed highly suspected 17 cases with HCV-related AIHA [19]. These authors suggested that a higher prevalence of immunologic markers including cryoglobulinemia and hypocomplementemia all support the hypothesis that HCV-related AIHA has an autoimmune pathogenesis caused by chronic HCV infection.

We concluded that renal involvement in our patient post-dated his development of AIHA, which occurred against the backdrop of a progressive autoimmune imbalance induced by chronic HCV infection.

List of abbreviations

(HCV): 

hepatitis C virus

(IC): 

immune complexes

(AIHA): 

autoimmune hemolytic anemia

(RBC): 

red blood cells

(GBM): 

glomerular basement membrane

(MN): 

membranous nephropathy

(OLT): 

orthotopic liver transplant

Declarations

Acknowledgements

Written consent to publish the details of his medical record was obtained from our patient prior to preparation of this manuscript.

Authors’ Affiliations

(1)
Internal medicine II Nihon University School of Medicine
(2)
Department of laboratory medicine, Nihon University School of Medicine
(3)
Clinical laboratory, Nihon University Itabashi hospital

References

  1. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia M, André C, Voisin MC, Intrator L, Zafrani ES, Duval J, Dhumeaux D: Extrahepatic Immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med. 1995, 122: 169-173.View ArticlePubMedGoogle Scholar
  2. Mcmurray RW, Elbourne K: Hepatitis C virus and autoimmunity. Semin Arthritis Rheum. 1997, 26: 689-701.View ArticlePubMedGoogle Scholar
  3. Ohsawa I, Ohi H, Endo M, Fujita T, Seki M, Watanabe S: High prevalence of hepatitis C virus antibodies in elder patients with membranoproliferative glomerulonephritis. Nephron. 1999, 82: 366-367. 10.1159/000045459.View ArticlePubMedGoogle Scholar
  4. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Forschi M, Maggi E, Romabnani S, Gentilini P, Bréchot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol. 1992, 15: 382-386.View ArticlePubMedGoogle Scholar
  5. Müller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L: Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus. J Gen virol. 1993, 74: 669-676.View ArticlePubMedGoogle Scholar
  6. Lutz HU, Bussolino F, Flepp R, Fasler S, Stammler P, Kazatchkine MD, Arese P: Naturally occurring anti-band 3 antibodies and complement together mediate phagocytosis of oxidatively stressed human erythrocyte. Proc Natl Acad Sci USA. 1987, 84: 7368-7372.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Wakui H, Imai H, Kobayashi R, Itoh H, Notoya T, Yoshida K, Nakamoto Y, Miura A: Autoantibody against erythrocyte protein 4.1 in a patient with autoimmune hemolytic anemia. Blood. 1988, 72: 408-412.PubMedGoogle Scholar
  8. Leddy JP, Falany JL, Kissel GE, Passador ST, Rosenfeld SI: Erythrocyte membrane proteins reactive with human (Warm-reacting) anti-red cell autoantibodies. J Clin Invest. 1993, 91: 1672-1680.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Franceschi LD, Fattovich G, Turrini F, Ayi K, Brugnara C, Manzato F, Noventa F, Stanzial AM, Solero P, Corrocher R: Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage. Hepatol. 2000, 31: 997-1004.View ArticleGoogle Scholar
  10. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Causer WG, Corey L, Wener MH, Alpers CE, Willson R: Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Eng J Med. 1993, 328: 465-701. 10.1056/NEJM199302183280703.View ArticleGoogle Scholar
  11. Stehman-Breen C, Alpers CE, Causer WG, Willson R, Johnson RJ: Hepatitis C virus associated membranous glomerulonephritis. Clin Nephrol. 1995, 44: 141-147.PubMedGoogle Scholar
  12. Ohsawa I, Ohi H, Tamano M, Endo M, Fujita T, Sotomura A, Hidaka M, Fuke Y, Matsushita M, Fujita T: Cryoprecipitate of patients with cryoglobulinemic glomerulonephritis contains molecules of the lectin complement pathway. Clin Immunol. 2001, 101: 59-66. 10.1006/clim.2001.5098.View ArticlePubMedGoogle Scholar
  13. Gournay J, Ferrell LD, Roberts JP, Ascher NL, Wright TL, Lake JR: Cryoglobulinemia presenting after liver transplamtation. Gastroenterol. 1996, 110: 265-270.View ArticleGoogle Scholar
  14. Ríos-Rull P, Rubio M, Ojeda E, Hemández Navarro F: Criøglobulinemia mixta esencial-hepatitis C positiva, anemia hemolytica autoimmune purpura thrombocitopenica immune. Sangre. 1994, 39: 225-PubMedGoogle Scholar
  15. Emilia G, Luppin M, Ferrari MG, Borozzi P, Marasca R, Torelli G: Hepatitis C virus-induced leuko-thrombocytopenia and hemolysis. J Med Virol. 1997, 53: 182-184. 10.1002/(SICI)1096-9071(19971003)53:2<182::AID-JMV12>3.0.CO;2-L.View ArticlePubMedGoogle Scholar
  16. Fellermann K, Stange E: Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology?. Hepatogastroenterol. 2000, 47: 1422-1424.Google Scholar
  17. Wei G, Yano S, Kuroiwa T, Hiromura K, Maezawa A: Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease. Clin Exp Immunol. 1997, 107: 83-88. 10.1046/j.1365-2249.1997.d01-882.x.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Dalekos GN, Kistis KG, Boumba DS, oulgari P, Zervou EK, Drosos AA, Tsianos EV: Increased incidence of anti-cardiolipin antibodies in patients with hepatitis C is not associated with aetiopathogenic link to anti-phospholipid syndrome. Eur J Gastoenterol hepat. 2000, 12: 67-74.View ArticleGoogle Scholar
  19. Ramos-Casals M, García-Carrasco M, López-Medrano F, Trejo O, Forns X, López-Guillermo A, Muñoz C, Ingelmo M, Font J: Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection; Clinical description of 35 cases. Medicine. 2003, 82: 87-96. 10.1097/00005792-200303000-00003.View ArticlePubMedGoogle Scholar
  20. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/4/7/prepub

Copyright

© Ohsawa et al; licensee BioMed Central Ltd. 2003

This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

Advertisement